Parra, Rogério Serafim https://orcid.org/0000-0002-5566-9284
de Sá Brito Fróes, Renata https://orcid.org/0000-0003-3256-4698
Magro, Daniela Oliveira https://orcid.org/0000-0002-8180-6254
da Costa Ferreira, Sandro https://orcid.org/0000-0001-7698-6599
de Mello, Munique Kurtz https://orcid.org/0009-0000-7728-6068
de Azevedo, Matheus Freitas Cardoso https://orcid.org/0000-0001-5487-9418
Damião, Aderson Omar Mourão Cintra https://orcid.org/0000-0001-7584-7351
de Sousa Carlos, Alexandre https://orcid.org/0000-0001-6485-7968
Barros, Luísa Leite https://orcid.org/0000-0002-7782-2825
de Miranda, Maria Luiza Queiroz https://orcid.org/0000-0002-1556-4138
Vieira, Andrea https://orcid.org/0000-0003-1858-3446
Sales, Marcos Paulo Moraes https://orcid.org/0000-0002-1449-8386
Zabot, Gilmara Pandolfo https://orcid.org/0000-0002-1253-4945
Cassol, Ornella Sari https://orcid.org/0000-0003-0867-6593
Tiburcio Alves, Antonio José Jr https://orcid.org/0000-0002-6795-8526
Lubini, Márcio https://orcid.org/0000-0003-2779-7841
Machado, Marta Brenner https://orcid.org/0000-0003-2266-2542
Flores, Cristina https://orcid.org/0000-0003-1623-4525
Teixeira, Fabio Vieira https://orcid.org/0000-0002-8915-7279
Coy, Claudio Saddy Rodrigues https://orcid.org/0000-0002-0916-4138
Zaltman, Cyrla https://orcid.org/0000-0002-5236-6501
Chebli, Liliana Andrade https://orcid.org/0000-0002-7875-1475
Sassaki, Ligia Yukie https://orcid.org/0000-0002-7319-8906
Féres, Omar https://orcid.org/0000-0003-3593-0526
Chebli, Júlio Maria Fonseca https://orcid.org/0000-0003-1527-0663
Article History
Received: 17 October 2024
Accepted: 29 January 2025
First Online: 18 March 2025
Declarations
:
: The study was approved by the Ethics Committee of the coordinating site, the Hospital das Clínicas of the Ribeirão Preto Medical School at the University of São Paulo, with the following approval details: CAAE 71008923.0.1001.5440; Ethics Committee Number 6.171.795/2023. Based on this ethical approval, we are authorized to retrospectively collect data from all patients receiving treatment with small molecules, such as tofacitinib. All procedures were conducted in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Not Applicable.
: Parra RS has received fees for serving as a speaker and/or an advisory board member for Takeda, Janssen, Abbvie, Celltrion and Pfizer. Fróes RSB has received fees for serving as a speaker and/or an advisory board member for Takeda, Janssen, Abbvie, and is a speaker for Celltrion, Nestle, Ferring, Pfizer, and CSL Vifor. Ferreira SC has received fees for serving as a speaker and/or an advisory board member for Janssen, Takeda, and Pfizer. Mello MK has received fees for serving as a speaker and/or an advisory board member for Takeda, Janssen, Abbvie, Sandoz and Ferring. Azevedo MFC has received fees for serving as a speaker and/or an advisory board member for Takeda, Abbvie, Pfizer and Janssen. Damião AOMC has received fees for serving as a speaker and/or an advisory board member for Takeda, Abbvie, Ferring, and Janssen Carlos AS has received fees for serving as a speaker and/or an advisory board member for Takeda, Janssen, Abbvie Miranda MLQ has received fees for serving as speaker for Takeda, Janssen and Abbvie Zabot GP has received fees for serving as a speaker and/or an advisory board member for Janssen, Abbvie, and Takeda. Cassol OS has received fees for serving as a speaker and/or an advisory board member for Nestle, Abbvie, Janssen, Takeda, and Buhlmann. Alves Junior AJT has received fees for serving as a speaker and/or an advisory board member for Janssen, Takeda, UCB, and Abbvie. Machado MB has received fees for serving as a speaker and/or na Advisory board for Takeda, Jassen, Abbvie, Ferring and Pfizer. Teixeira FV is a speaker and an advisory board member of Takeda. Chebli JMF has received fees for serving as a speaker and/or an advisory board member for Takeda, Janssen, AbbVie, Abbott, and Sandoz. Magro, DO, Sales MPM, Barros LL, Sassaki LY, Flores C, Vieira A, Lubini M, Coy CSR, Zaltmann C, and Féres O report no conflicts of interest.